Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
UGT1A6
REST API REST API
Homo sapiens
UGT1A6 is differentially expressed in 183 experiments: 127 organism parts: liver, kidney, ... (125 more);, 144 disease states: normal, colon carcinoma, ... (142 more);, 38 cell types 426 cell lines 24 compound treatments and 60 other conditions.
Synonyms GNT1, HLUGP, UGT1F
Orthologs ugt1b4 (Danio rerio)   ugt1ab (Danio rerio)   Ugt1a6a (Mus musculus)   Ugt1a6b (Mus musculus)   (Compare orthologs)
Gene Ontology Term endoplasmic reticulum, transferase activity, transferring hexosyl groups, membrane, lipid glycosylation, carbohydrate binding, metabolic process, microsome, protein heterodimerization activity, carbohydrate metabolic process, protein homodimerization activity, integral to membrane, glucuronosyltransferase activity, endoplasmic reticulum membrane, enzyme binding, xenobiotic metabolic process
InterPro Term UDP_glucos_trans, Glyco_trans_28_C
UniProt Accession Q5DSZ8, B5MCT4, C9JMY5, P19224, A6NKK6
Search EB-eye ENSG00000167165
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-MTAB-24, E-MTAB-25, E-TABM-130, E-TABM-145, ... (18 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (33 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-19639, E-GEOD-20081, E-GEOD-3529, E-GEOD-5823
A549
2
E-GEOD-3202, E-GEOD-6013
AGS
2
E-MTAB-37, E-GEOD-15460
BT20
2
E-MTAB-37, E-MTAB-62
HCC1937
2
E-MTAB-37, E-MTAB-62
HCC1954
2
E-MTAB-37, E-GEOD-29119
420 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-22373, E-GEOD-19397, E-GEOD-29119, ... (22 experiments)

Factor Value U/D Experiments
2
E-TABM-145, E-TABM-130
human embryonic stem cell
1
E-GEOD-18265
cancer cell culture
1
E-GEOD-14990
memory B cell
1
E-MEXP-2360
hematopoietic
1
E-GEOD-9894
epidermoid
1
E-GEOD-19397
32 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-20602, E-MTAB-62, ... (34 experiments)

Factor Value U/D Experiments
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
acute promyelocytic leukemia
2
E-MTAB-62, E-GEOD-1729
adenocarcinoma
2
E-MTAB-37, E-MTAB-62
colorectal carcinoma
2
E-GEOD-23878, E-MTAB-37
prostate carcinoma
2
E-MTAB-62, E-MEXP-2034
colon carcinoma
1
2
E-MTAB-37, E-GEOD-3726, E-MTAB-57
138 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-5099, E-GEOD-4006, E-MEXP-1269, E-GEOD-3284, ... (13 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-3284, E-GEOD-4006
interleukin-24 (Homo sapiens)
1
E-GEOD-7216
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
unknown
1
E-GEOD-7307
glutamine
1
E-MEXP-1335
18 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
126.19
1
1
E-TABM-325
101.34
1
1
E-TABM-325
91.08
1
1
E-TABM-325
87.05
1
1
E-TABM-325
93.96
1
1
E-TABM-325


Age at diagnosis
studied in E-GEOD-3494, E-GEOD-4922

Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-GEOD-3320, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, ... (11 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-2666, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-GEOD-21138, E-GEOD-1751 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7578, E-MTAB-108

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-MEXP-421, E-GEOD-18005, E-TABM-601, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-440, E-MEXP-2146

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-TABM-666, E-GEOD-19330, ... (23 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958, E-MEXP-1082

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-3407, E-GEOD-17636

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-GEOD-2748

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 99 146
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.41 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM